SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-013502
Filing Date
2019-11-06
Accepted
2019-11-06 16:25:16
Documents
15
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-2019xq3x8xk.htm   iXBRL 8-K 55948
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 82932
  Complete submission text file 0001628280-19-013502.txt   291179

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20191106.xsd EX-101.SCH 4608
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20191106_cal.xml EX-101.CAL 645
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20191106_def.xml EX-101.DEF 1495
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20191106_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20191106_pre.xml EX-101.PRE 13601
12 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-2019xq3x8xk_htm.xml XML 4465
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 191196677
SIC: 2836 Biological Products, (No Diagnostic Substances)